Skip Navigation

Skip Navigation

Issue No. 5  | January 30, 2009
View HTML version

AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful.

Globe of the earth

National Black HIV/AIDS Awareness Day 2009

February 7, 2009, marks the ninth annual National Black HIV/AIDS Awareness Day (NBHAAD). NBHAAD is a day dedicated to increasing awareness of HIV/AIDS in the African-American community. The goals of NBHAAD are to educate African Americans about HIV/AIDS and how it is transmitted, to encourage them to get tested, to motivate HIV-infected African Americans to seek proper treatment, and to inspire people to get involved in their community. 

Check out the updated Department of Health and Human Services' National Black HIV/AIDS Awareness Day Web page, which includes helpful links to sites providing information on health disparities, HIV/AIDS statistics, and much more--all specific to African Americans.

AIDSinfo encourages you to participate in NBHAAD by sharing this information with others.


Negative Effect of HIV and HAART on Arteries

"HIV-infected patients using combination antiretroviral therapy (ART) have an increased cardiovascular risk. We aimed to identify the effects of HIV, ART, and lipodystrophy (LD) on carotid artery intima-media thickness (C-IMT), a surrogate measure of atherosclerosis, and arterial stiffness, a marker of cardiovascular risk. ... HIV infection is independently associated with C-IMT and generally increased arterial stiffness. ART use is associated with increased stiffness of the femoral artery."


HAART Improves Survival in HIV-Infected People with Non-Small-Cell Lung Cancer

"To evaluate the impact of highly active antiretroviral therapy (HAART) on survival in HIV infected patients with non-small-cell lung cancer (NSCLC)...[a]ll consecutive HIV infected patients with NSCLC diagnosed between 06/1996 and 03/2007 at two University hospitals in Paris (France) were prospectively followed until death. The association between survival and clinical and biological factors was analyzed[.] ... Conclusion: HAART is a good prognostic factor for survival in HIV infected patients with NSCLC."


ClinicalTrials.gov Info

Subscribe Info

Contact AIDSinfo
Download Adobe Acrobat(R) Reader TM to view PDF files located on this site.
ISSN 1558-3228





previewPage